HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab.
| Image |  |
|---|---|
| Description | scientific article published in November 2002 |
| Author/s |
author: Shigeru Saito Noriyuki Katsumata |
| Publication date | November 1, 2002 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |